GO:0043199 sulfate binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043199 sulfate binding is a molecular function defined as binding to sulfate, SO4(2-), a negatively charged small molecule.
• Sulfate binding is central to the transport, metabolism, and cellular retention of sulfate-conjugated compounds such as sulfated steroids and bile acids.
• Many sulfate-binding proteins recognize sulfated glycosaminoglycans (heparan sulfate, heparin), influencing growth factor signaling and extracellular matrix interactions.
• Dysregulated sulfate binding contributes to human disease, including hearing loss (DFNA9), amyloid cytotoxicity, and cancer progression.
• Key experimental approaches include binding assays, NMR relaxometry, and CRISPR-based knockout or point-mutation models to test causality.
• EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models and CRISPR library screening to study sulfate-binding proteins.
Description
Sulfate binding (GO:0043199) is a molecular function that describes the non-covalent interaction of a protein or other biomolecule with the sulfate ion, SO4(2-), a small, doubly negatively charged molecule. This function is distinct from sulfate transport or sulfate conjugation; it specifically refers to the binding event itself. Sulfate binding underlies the recognition of sulfated metabolites, sulfated glycosaminoglycans, and sulfated drugs by cellular and extracellular proteins. For researchers, GO:0043199 provides a precise annotation for proteins that directly engage sulfate groups, enabling functional comparisons across species and experimental systems. The biological importance of sulfate binding spans drug metabolism, extracellular matrix biology, and disease mechanisms. For example, the liver relies on sulfate binding and transport to handle sulfate-conjugated compounds, affecting their clearance and retention. In the extracellular matrix, sulfate-binding proteins such as cochlin interact with sulfated heparan sulfate, and mutations that alter this binding cause autosomal dominant late-onset hearing loss (DFNA9). Similarly, the Iowa mutation of apolipoprotein A-I (ApoA-IIowa) forms amyloid whose cytotoxicity is mediated by sulfate moieties of heparan sulfate, highlighting sulfate binding in amyloid disease. Because sulfate binding is a discrete molecular function, it can be studied with targeted biochemical assays and perturbed with CRISPR genome editing. This article summarizes the definition, mechanism, key genes, disease links, and research methods for GO:0043199, with all factual claims supported by published literature.
sulfate binding At A Glance
| GO ID | GO:0043199 |
|---|---|
| GO term | sulfate binding |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Binding to sulfate, SO4(2-), a negatively charged small molecule. |
| Major function | Non-covalent recognition of sulfate ions and sulfate groups on biomolecules. |
| Related processes | Sulfate conjugate transport and metabolism, glycosaminoglycan-protein interactions, amyloid cytotoxicity. |
| Example proteins | Serum albumin, cochlin, neuropilin-1, apolipoprotein A-I. |
| Disease relevance | Hearing loss (DFNA9), amyloid disease, cancer, and drug disposition. |
What Is GO:0043199?
According to the Gene Ontology, sulfate binding (GO:0043199) is the molecular function of binding to sulfate, SO4(2-), a negatively charged small molecule. In practical terms, it is the ability of a protein or other macromolecule to form a reversible, non-covalent complex with the sulfate ion. This function is annotated when experimental evidence demonstrates direct interaction with sulfate, such as by binding assays, structural studies, or affinity measurements. It does not imply catalysis, transport, or covalent modification; those are separate functions.
Why Is sulfate binding Important in Cell Biology?
Sulfate binding is important because sulfate groups are ubiquitous in biology, appearing on glycosaminoglycans, sulfated steroids, bile acids, and many drugs. Proteins that bind sulfate control the fate of these molecules, from hepatic clearance of sulfate conjugates to growth factor signaling in the extracellular matrix. Disrupting sulfate binding can cause disease, as seen in DFNA9 hearing loss and amyloid cytotoxicity. Therefore, GO:0043199 is a key annotation for understanding molecular recognition, drug metabolism, and disease mechanisms.
• Sulfate binding mediates the hepatic transport and metabolism of sulfate-conjugated compounds, affecting drug and hormone clearance.
• It enables recognition of sulfated glycosaminoglycans such as heparan sulfate and heparin, which modulate growth factor signaling.
• Cochlin binding to sulfated heparan sulfate is involved in the pathophysiology of autosomal dominant late-onset hearing loss (DFNA9).
• Sulfate moieties of heparan sulfate mediate the cellular interaction and cytotoxicity of ApoA-IIowa amyloid.
• Serum albumin binds lithocholate sulfate, influencing bile acid transport and cholestatic liver disease.
• Sulfate binding is a target for probing tumor cell heparan sulfate interactions with metal complexes.
• Methylene blue binding to heparin depends on sulfate level, illustrating sulfate-dependent molecular recognition.
• Gd(3+) ion binding to glycosaminoglycans is influenced by sulfate groups, relevant to contrast agents and imaging.
• Sulfate-binding proteins are candidate biomarkers and therapeutic targets in cancer and neurodegeneration.
• CRISPR models of sulfate-binding genes can test causality in disease and validate drug targets.
Molecular Mechanism of sulfate binding
Recognition of the sulfate ion
In simple terms: The protein has a pocket that fits the sulfate ion, using positive charges to hold the negatively charged sulfate.
Sulfate is a tetrahedral dianion with four oxygen atoms. Proteins that bind sulfate typically present positively charged residues (arginine, lysine, histidine) or backbone amides that form hydrogen bonds and electrostatic interactions with the sulfate oxygens. This binding is non-covalent and reversible. For example, serum albumin binds lithocholate sulfate, a sulfated bile acid, through such interactions. The specificity for sulfate over other anions depends on the geometry and charge distribution of the binding site.
Binding to sulfated glycosaminoglycans
In simple terms: Many proteins do not bind free sulfate but instead recognize sulfate groups attached to long sugar chains like heparan sulfate.
Heparan sulfate and heparin are glycosaminoglycans decorated with sulfate groups. Proteins such as cochlin bind to these sulfated chains, and the degree of sulfation affects binding strength. Methylene blue binding to heparin depends on its sulfate level rather than the exact sulfation location or saccharide structure. Similarly, triplatin complexes bind disaccharides as models for tumor cell heparan sulfate interactions. These examples show that sulfate binding often occurs in the context of a sulfated polymer, where multiple sulfate groups cooperate.
Sulfation-dependent protein-protein interactions
In simple terms: Sulfate groups can act like switches that turn protein interactions on or off.
3-O-sulfation of heparan sulfate enhances binding of neuropilin-1, modulating its activity. This demonstrates that a single sulfate group at a specific position can change protein-protein interactions and downstream signaling. Such sulfation-dependent binding is critical in development, angiogenesis, and cancer. The interaction is not merely electrostatic; it requires a complementary binding surface that recognizes the sulfated epitope.
Metal ion coordination by sulfate groups
In simple terms: Sulfate groups can also hold metal ions, which is important for imaging and therapy.
Gd(3+) ions bind to glycosaminoglycans, and this binding is influenced by sulfate groups, as shown by NMR relaxometry. This property is exploited in contrast agents for magnetic resonance imaging and suggests that sulfate-binding sites can coordinate metals. The interplay between metal ions and sulfate groups adds another layer of regulation to sulfate-binding proteins.
Cellular consequences of sulfate binding
In simple terms: When a protein binds sulfate, it can change how cells take up, retain, or respond to molecules.
In the liver, sulfate binding and transport influence the disposition of sulfate conjugates, affecting their excretion and biological effects. In amyloid disease, sulfate moieties of heparan sulfate mediate the cellular interaction and cytotoxicity of ApoA-IIowa amyloid. Thus, sulfate binding is not just a biochemical curiosity; it has direct consequences for cell physiology and disease.
Key Genes Involved in GO:0043199 sulfate binding
The following genes and proteins have been experimentally linked to sulfate binding or sulfate-dependent interactions, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ALB | Binds lithocholate sulfate and other sulfated compounds | Model for hepatic drug and bile acid transport |
| COCH | Cochlin binds sulfated heparan sulfate/heparin | DFNA9 hearing loss pathophysiology |
| NRP1 | Neuropilin-1 binds 3-O-sulfated heparan sulfate | Modulates growth factor signaling in cancer |
| APOA1 | ApoA-I Iowa mutant interacts with heparan sulfate sulfate moieties | Amyloid cytotoxicity model |
| HSPG2 | Perlecan, a heparan sulfate proteoglycan | Extracellular matrix sulfate binding |
| GPC1 | Glypican-1, heparan sulfate proteoglycan | Cell surface sulfate-dependent signaling |
| SDC1 | Syndecan-1, heparan sulfate proteoglycan | Tumor cell heparan sulfate interactions |
| EXT1 | Heparan sulfate biosynthesis | Determines sulfation level for binding |
| EXT2 | Heparan sulfate biosynthesis | Affects sulfate-dependent protein interactions |
| NDST1 | N-deacetylase/N-sulfotransferase | Regulates heparan sulfate sulfation |
| HS3ST1 | 3-O-sulfotransferase | Generates 3-O-sulfated heparan sulfate for neuropilin-1 binding |
| SULT2A1 | Sulfotransferase for bile acids and steroids | Produces sulfate conjugates that are bound and transported |
| SLCO1B1 | Organic anion transporting polypeptide | Uptake of sulfate conjugates in liver |
| ABCC2 | Multidrug resistance protein 2 | Efflux of sulfate conjugates |
| LGALS3BP | Lectin galactoside-binding soluble 3 binding protein | Sulfate-dependent interactions in matrix |
| FGF2 | Fibroblast growth factor 2 | Heparan sulfate-dependent signaling |
| VEGFA | Vascular endothelial growth factor A | Heparan sulfate-dependent angiogenesis |
How Is sulfate binding Regulated?
Sulfate binding can be regulated at multiple levels. The availability of sulfate groups on glycosaminoglycans is controlled by sulfotransferases (e.g., HS3ST1) and sulfatases, which add or remove sulfate, thereby altering binding sites for proteins such as neuropilin-1. In the liver, the expression of transporters and conjugating enzymes regulates the concentration of sulfate conjugates available for binding to serum albumin and other proteins. Additionally, the extracellular matrix composition and pH can influence electrostatic interactions between sulfate groups and binding proteins. Thus, sulfate binding is not static but dynamically regulated by biosynthetic enzymes, transporters, and the local environment.
sulfate binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| COCH | DFNA9 hearing loss | Knock-in of DFNA9 mutations in cell lines; binding assays with sulfated heparan sulfate |
| APOA1 | Amyloid disease | Overexpression of ApoA-IIowa in cells; sulfate-dependent cytotoxicity assays |
| NRP1 | Cancer angiogenesis | Knockout of NRP1 or HS3ST1; 3-O-sulfated heparan sulfate binding assays |
| ALB | Cholestatic liver disease | Point mutations in albumin sulfate-binding site; lithocholate sulfate binding assays |
| SULT2A1 | Drug metabolism | Knockout of SULT2A1; sulfate conjugate transport and binding studies |
Sulfate binding in hearing loss (DFNA9)
Mutations in COCH cause autosomal dominant late-onset hearing loss (DFNA9). Cochlin binds to sulfated heparan sulfate/heparin, and this interaction is involved in the pathophysiology of the disease. Disrupted sulfate binding may lead to protein aggregation or altered matrix interactions in the inner ear, contributing to progressive hearing loss. This makes sulfate binding a potential target for therapeutic intervention.
Sulfate binding in amyloid disease
The Iowa mutation of apolipoprotein A-I (ApoA-IIowa) forms amyloid deposits. Cellular interaction and cytotoxicity of this amyloid are mediated by sulfate moieties of heparan sulfate. This suggests that sulfate binding is a key step in amyloid toxicity and that blocking sulfate interactions could be therapeutic. The findings also highlight the general role of heparan sulfate in amyloidoses.
Sulfate binding in cancer
Sulfated heparan sulfate proteoglycans on tumor cells interact with growth factors and receptors. Neuropilin-1 binding to 3-O-sulfated heparan sulfate modulates its activity, influencing angiogenesis and tumor progression. Triplatin complexes have been used to probe disaccharide binding as models for tumor cell heparan sulfate interactions. Therefore, sulfate binding is relevant to cancer biology and drug design.
Sulfate binding in liver and drug metabolism
The liver handles sulfate conjugates of bile acids, steroids, and drugs. Serum albumin binds lithocholate sulfate, affecting its transport and toxicity. Transport, binding, and metabolism of sulfate conjugates in the liver determine their clearance and biological effects. Dysregulation of these processes can contribute to cholestasis and drug-induced liver injury.
From sulfate binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a sulfate-binding protein alter ligand clearance? | Knockout cell model (e.g., ALB or SLCO1B1 KO) |
| Does a specific sulfate-binding residue mediate interaction? | Point-mutation knock-in of binding-site residues |
| Can a disease mutation be corrected? | Knock-in of wild-type gene or correction of mutation |
| Does overexpression of a sulfate-binding protein increase ligand retention? | Overexpression cell model |
| Which genes regulate sulfation for binding? | CRISPR library screening for sulfation modifiers |
| Can we tag a sulfate-binding protein to track localization? | Tagged knock-in (e.g., GFP) |
How to Study the sulfate binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isothermal titration calorimetry | Binding affinity and thermodynamics | Characterize sulfate binding to purified proteins |
| Surface plasmon resonance | Real-time binding kinetics | Measure sulfate-protein interactions |
| NMR relaxometry | Metal ion binding influenced by sulfate | Study Gd(3+) binding to glycosaminoglycans |
| Cell cytotoxicity assay | Sulfate-dependent cellular toxicity | Test amyloid cytotoxicity |
| CRISPR knockout | Loss-of-function of sulfate-binding genes | Determine causality in disease models |
| CRISPR point mutation | Effect of specific residues | Map sulfate-binding site |
| Overexpression | Gain-of-function | Increase sulfate-binding protein levels |
| CRISPR library screening | Identify regulators of sulfation | Discover new sulfate-binding pathways |
Binding assays
Direct binding of sulfate or sulfated compounds to proteins can be measured using equilibrium dialysis, surface plasmon resonance, or isothermal titration calorimetry. For example, binding of lithocholate sulfate to human serum albumin was characterized by such methods. These assays provide affinity constants and stoichiometry.
NMR relaxometry and spectroscopy
NMR relaxometry has been used to investigate the role of sulfate groups in the binding of Gd(3+) ions to glycosaminoglycans. NMR can also detect sulfate-binding epitopes and conformational changes. This method is valuable for studying weak or transient interactions.
Cell-based binding and cytotoxicity assays
Cellular interaction and cytotoxicity of amyloid proteins mediated by heparan sulfate can be tested in cell culture. For instance, ApoA-IIowa amyloid cytotoxicity was shown to depend on sulfate moieties of heparan sulfate. Such assays link sulfate binding to functional outcomes.
CRISPR screening and bioinformatics
CRISPR library screening can identify genes that regulate sulfation and sulfate binding. Bioinformatics analysis of transcriptomic data can reveal expression patterns of sulfate-binding proteins. These approaches are supported by studies on heparan sulfate sulfation and neuropilin-1 binding.
How CRISPR Can Be Used to Study GO:0043199 sulfate binding
Knockout
CRISPR knockout of genes encoding sulfate-binding proteins or sulfation enzymes can abolish sulfate binding and reveal its cellular functions. For example, knocking out COCH or HS3ST1 would test the role of sulfate binding in hearing loss or cancer signaling. Knockout models are essential for establishing causality.
Point Mutation
Point mutations can be introduced into the sulfate-binding site to disrupt specific interactions without affecting protein expression. This is useful for mapping the contribution of individual residues, as seen in studies of cochlin binding to sulfated heparan sulfate. Point-mutation models help distinguish binding from other functions.
Knock-in
Knock-in of disease-associated mutations or tagged versions of sulfate-binding proteins allows tracking and functional analysis. For example, knocking in the DFNA9 mutation in COCH can model hearing loss. Tagged knock-in (e.g., GFP) enables imaging of protein localization.
Overexpression
Overexpression of sulfate-binding proteins can enhance ligand retention and amplify downstream effects. Overexpressing ApoA-IIowa in cells increases amyloid formation and sulfate-dependent cytotoxicity. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports sulfate binding Research
Researchers studying sulfate binding-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. CRISPR-based models provide a direct way to perturb gene function and observe the consequences on sulfate binding, cellular behavior, and disease phenotypes. EDITGENE offers a comprehensive suite of services to support such studies.
Contact EDITGENE today to design your custom CRISPR model for sulfate binding research.
Frequently Asked Questions About sulfate binding
What is sulfate binding?
Sulfate binding (GO:0043199) is the molecular function of binding to the sulfate ion, SO4(2-), a negatively charged small molecule. It involves non-covalent recognition of sulfate or sulfate groups on biomolecules.
What genes are involved in sulfate binding?
Genes such as ALB, COCH, NRP1, APOA1, and various heparan sulfate proteoglycans and sulfotransferases are involved in sulfate binding or sulfate-dependent interactions.
What is GO:0043199?
GO:0043199 is the Gene Ontology identifier for the molecular function sulfate binding, defined as binding to sulfate, SO4(2-).
How is sulfate binding studied?
It is studied using binding assays, NMR relaxometry, cell-based assays, and CRISPR genome editing to perturb genes.
What diseases are linked to sulfate binding?
Diseases include DFNA9 hearing loss, amyloid disease, cancer, and liver disorders related to bile acid transport.
What is the role of heparan sulfate in sulfate binding?
Heparan sulfate is a sulfated glycosaminoglycan that presents sulfate groups for protein binding, influencing signaling and disease.
Can CRISPR be used to study sulfate binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can test the function of sulfate-binding proteins and their disease relevance.
What proteins bind sulfate?
Examples include serum albumin, cochlin, neuropilin-1, and apolipoprotein A-I, as well as many extracellular matrix proteins.
Why is sulfate binding important in cancer?
Sulfate binding mediates interactions between heparan sulfate proteoglycans and growth factors, affecting angiogenesis and tumor progression.
How does sulfate binding affect drug metabolism?
Sulfate binding influences the transport and clearance of sulfate-conjugated drugs and metabolites in the liver.
Conclusion
Sulfate binding (GO:0043199) is a fundamental molecular function that underlies the recognition of sulfate ions and sulfated biomolecules. It plays critical roles in liver metabolism, extracellular matrix signaling, hearing, and disease processes such as amyloidosis and cancer. Understanding sulfate binding requires integrating biochemical, cellular, and genetic approaches. CRISPR-based models offer powerful tools to dissect the causal roles of sulfate-binding proteins. EDITGENE provides comprehensive services to support such research, from knockout and point-mutation models to library screening and bioinformatics.
References
- 1. Pang KS et al.. 1994. Transport, binding, and metabolism of sulfate conjugates in the liver.. Chem Biol Interact 92(1-3):179-207 PMID: 8033253
- 2. Gorle AK et al.. 2023. Probing Disaccharide Binding to Triplatin as Models for Tumor Cell Heparan Sulfate (GAG) Interactions.. Inorg Chem 62(33):13212-13220 PMID: 37552525
- 3. Jia SX et al.. 2021. Binding ability of methylene blue with heparin dependent on its sulfate level rather than its sulfation location or basic saccharide structure.. Glycoconj J 38(5):551-560 PMID: 34515908
- 4. Honda T et al.. 2022. Involvement of cochlin binding to sulfated heparan sulfate/heparin in the pathophysiology of autosomal dominant late-onset hearing loss (DFNA9).. PLoS One 17(7):e0268485 PMID: 35901072
- 5. Thacker BE et al.. 2016. Expanding the 3-O-Sulfate Proteome--Enhanced Binding of Neuropilin-1 to 3-O-Sulfated Heparan Sulfate Modulates Its Activity.. ACS Chem Biol 11(4):971-80 PMID: 26731579
- 6. Werner P et al.. 2022. Investigating the Role of Sulfate Groups for the Binding of Gd(3+) Ions to Glycosaminoglycans with NMR Relaxometry.. ChemMedChem 17(13):e202100764 PMID: 35451227
- 7. Takikawa H et al.. 1995. Binding of lithocholate and its glucuronide and sulfate by human serum albumin.. Biochim Biophys Acta 1244(2-3):277-82 PMID: 7599144
- 8. Kuwabara K et al.. 2015. Cellular interaction and cytotoxicity of the iowa mutation of apolipoprotein A-I (ApoA-IIowa) amyloid mediated by sulfate moieties of heparan sulfate.. J Biol Chem 290(40):24210-21 PMID: 26292220
